Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

Blocking certain proteins on immune cells may help treat alopecia areata.

Immunological treatment improved both neuropathy and alopecia.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

Immunoadsorption successfully treated a man's resistant polymyositis.

B cells can both help and hinder the body's defense against melanoma.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Topical minoxidil effectively and safely treats extensive alopecia areata but doesn't change its course.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Nanomedicine-based immunotherapy shows promise in improving tissue repair and regeneration.

Targeted immunological therapies offer safer and more effective treatments for skin conditions like eczema and psoriasis.

Sequential immunotherapy can effectively treat alopecia areata by managing inflammation and promoting hair regrowth.

Aging and chronic inflammation weaken the immune system, increasing cancer and infection risks.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Biomaterials with MSC-derived substances could improve tissue repair and have advantages over direct cell therapy.

Edible seeds from the Cucurbitaceae family like pumpkin and watermelon seeds are nutritious and may have health benefits, but eating too much can cause side effects.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Enhancing glycolysis in mesenchymal stromal/stem cells boosts their immune functions and therapy potential.